India · Delayed Price · Currency is INR GKB Ophthalmics Statistics
Total Valuation
GKB Ophthalmics has a market cap or net worth of INR 265.24 million. The enterprise value is 324.90 million.
| Market Cap | 265.24M |
| Enterprise Value | 324.90M |
Important Dates
The next estimated earnings date is Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GKB Ophthalmics has 5.04 million shares outstanding. The number of shares has increased by 0.15% in one year.
| Current Share Class | 5.04M |
| Shares Outstanding | 5.04M |
| Shares Change (YoY) | +0.15% |
| Shares Change (QoQ) | -0.28% |
| Owned by Insiders (%) | 67.65% |
| Owned by Institutions (%) | 4.02% |
| Float | 1.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.18 |
| PB Ratio | 0.46 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.89 |
| EV / Sales | 0.22 |
| EV / EBITDA | 14.96 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 6.69 |
| Debt / FCF | n/a |
| Interest Coverage | -0.52 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -1.77% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.39% |
| Revenue Per Employee | 8.84M |
| Profits Per Employee | -148,282 |
| Employee Count | 170 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GKB Ophthalmics has paid 3.14 million in taxes.
| Income Tax | 3.14M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.47% in the last 52 weeks. The beta is 0.24, so GKB Ophthalmics's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -28.47% |
| 50-Day Moving Average | 55.56 |
| 200-Day Moving Average | 65.58 |
| Relative Strength Index (RSI) | 41.90 |
| Average Volume (20 Days) | 6,558 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GKB Ophthalmics had revenue of INR 1.50 billion and -25.21 million in losses. Loss per share was -5.00.
| Revenue | 1.50B |
| Gross Profit | 414.18M |
| Operating Income | -10.38M |
| Pretax Income | -19.08M |
| Net Income | -25.21M |
| EBITDA | 21.89M |
| EBIT | -10.38M |
| Loss Per Share | -5.00 |
Balance Sheet
The company has 133.75 million in cash and 146.53 million in debt, with a net cash position of -12.78 million or -2.54 per share.
| Cash & Cash Equivalents | 133.75M |
| Total Debt | 146.53M |
| Net Cash | -12.78M |
| Net Cash Per Share | -2.54 |
| Equity (Book Value) | 572.45M |
| Book Value Per Share | 104.11 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 27.56%, with operating and profit margins of -0.69% and -1.68%.
| Gross Margin | 27.56% |
| Operating Margin | -0.69% |
| Pretax Margin | -1.27% |
| Profit Margin | -1.68% |
| EBITDA Margin | 1.46% |
| EBIT Margin | -0.69% |
| FCF Margin | n/a |
Dividends & Yields
GKB Ophthalmics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.15% |
| Shareholder Yield | -0.15% |
| Earnings Yield | -9.50% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |